Background: Laparoscopic surgery in patients with endometrial cancer has been more widely used in the last 5-10 years, and numerous reports concerning recurrence rate and the surgical technique, laparoscopic vs. open, have been published. However, no data are available concerning the surgical technique of an open or closed vaginal cuff and the vaginal recurrence rate in patients with endometrial cancer.

Patients And Methods: Medical records of 273 patients with endometrial cancer first diagnosed between January 2000 and December 2005 have been reviewed. All patients underwent total abdominal hysterectomy (TAH) or laparoscopically assisted vaginal hysterectomy (LAVH), bilateral salpingo-oophorectomy, peritoneal washings at the Department of Gynecology and Obstetrics of the Medical University of Vienna, Austria. Pelvic lymphadenectomy was performed in high risk patients with grade 3, grade 2 > 2 cm diameter, adeno-squamous, clear cell or papillary serous histology, tumor invading the outer half of the myometrium and cervical extension.

Results: Thirty-two out of 273 patients with endometrial cancer had recurrent disease. Sixteen patients out of 126 with primary closure of the vaginal cuff had recurrent disease, 8 of them locally; 12 patients out of 130 with open vaginal cuff had recurrent disease, 6 of them locally. Four patients out of 17 with no available information had recurrent disease, 2 of them locally. No significant correlation between the local recurrence rate and surgical technique was found (Spearman's correlation coefficient 0.001, p = 0.994).

Conclusion: The surgical technique of an open or closed vaginal cuff during open or laparoscopic surgery for endometrial cancer showed no significant impact on the local recurrence rate.

Download full-text PDF

Source

Publication Analysis

Top Keywords

endometrial cancer
20
patients endometrial
16
recurrence rate
16
surgical technique
16
vaginal cuff
16
recurrent disease
16
local recurrence
12
disease locally
12
patients
9
laparoscopic surgery
8

Similar Publications

Background: Most cancer survivors have multiple cardiovascular risk factors, increasing their risk of poor cardiovascular and cancer outcomes. The Automated Heart-Health Assessment (AH-HA) tool is a novel electronic health record clinical decision support tool based on the American Heart Association's Life's Simple 7 cardiovascular health (CVH) metrics to promote CVH assessment and discussion in outpatient oncology. Before proceeding to future implementation trials, it is critical to establish the acceptability of the tool among providers and survivors.

View Article and Find Full Text PDF

Background: Endometrial cancer is the sixth leading cause of cancer among females and about 97,000 global deaths of endometrial cancer. The changes in the trends of obesity, fertility rates and other risk factors in South Africa (SA) may impact the endometrial cancer trends. The aim of this study was to utilise the age period cohort and join point regression modelling to evaluate the national and ethnic trends in endometrial cancer mortality in South Africa over a 20year period (1999-2018).

View Article and Find Full Text PDF

Background: Talabostat, an oral small molecule inhibitor of dipeptidyl peptidases (DPP4 and DPP8/9), has shown synergistic activity with immune checkpoint inhibitors in preclinical studies. This open label, phase 2 basket trial assessed the antitumor activity of combining talabostat and pembrolizumab (anti-programmed death-1 antibody) in advanced solid tumor patients.

Methods: The primary objective was assessment of dose-limiting toxicity (DLT) rates in the first six patients (lead-in stage) and response rate (efficacy stage; included cohort A [checkpoint inhibitor (ICI) naive] and cohort B [ICI pretreated]) for the study treatment using the Response Evaluation Criteria in Solid Tumors (RECIST) v1.

View Article and Find Full Text PDF

Objective: To evaluate the efficacy of immune checkpoint inhibitors (ICIs) for fertility-sparing treatment in Lynch syndrome-associated endometrial cancer (LS-EC).

Methods: Four LS-EC cases received programmed cell death protein 1 (PD-1) inhibitors for fertility preservation at the Obstetrics and Gynecology Hospital of Fudan University from 2017 to 2023. The clinical data and long-term outcomes were retrospectively reviewed.

View Article and Find Full Text PDF

Objective: To determine the accuracy of aspiration biopsy (AB), hysteroscopic biopsy (HB), and dilatation & curettage (D&C) in detecting uterine carcinosarcoma (UCS).

Methods: Pathology reports were retrieved from the Dutch Nationwide Pathology Databank PALGA for patients with a certain or suggested diagnosis of UCS in pre- and/or postoperative histology between 2001 and 2021. Patients without available pre- or postoperative pathology reports were excluded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!